SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

________________

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN THE STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)

(Amendment No. 1)*

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

---

 

 

Page 2 of 10

1	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)   Morton I. Sosland
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a)    [  ] (b)    [X]
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION   United States of America
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	SOLE VOTING POWER 5 3,388,389
	SHARED VOTING POWER 6 0
	SOLE DISPOSITIVE POWER 7 3,388,389
	SHARED DISPOSITIVE POWER 8 0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   3,388,389
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	[  ]
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)   11.53%
12	TYPE OF REPORTING PERSON   IN

---

Page 3 of 10

1	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)   David N. Sosland Trust A
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a)    [  ] (b)    [X]
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION   Missouri
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	SOLE VOTING POWER 5 707,287
	SHARED VOTING POWER 6 0
	SOLE DISPOSITIVE POWER 7 707,287
	SHARED DISPOSITIVE POWER 8 0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   707,287
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	[  ]
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)   2.41%
12	TYPE OF REPORTING PERSON   OO

---

Page 4 of 10

1	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)   The Sosland Family Trust B Partnership
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a)    [  ] (b)    [X]
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION   Missouri
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	SOLE VOTING POWER 5 1,948,554
	SHARED VOTING POWER 6 0
	SOLE DISPOSITIVE POWER 7 1,948,554
	SHARED DISPOSITIVE POWER 8 0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   1,948,554
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	[  ]
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)   6.63%
12	TYPE OF REPORTING PERSON   PN

---

Page 5 of 10

1	NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)   The Sosland Foundation
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a)    [  ] (b)    [X]
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION   Missouri
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	SOLE VOTING POWER 5 732,548
	SHARED VOTING POWER 6 0
	SOLE DISPOSITIVE POWER 7 732,548
	SHARED DISPOSITIVE POWER 8 0
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   732,548
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES	[  ]
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)   2.49%
12	TYPE OF REPORTING PERSON   CO

---

Page 6 of 10

 

Item 1(a).	Name of Issuer:
	Intra-Cellular Therapies, Inc.
Item 1(b).	Address of Issuer’s Principal Executive Offices:
	3960 Broadway New York, New York 10032
Items 2(a) and (b).	Name of Persons Filing and Address of Principal Business Office:
	Morton I. Sosland 4801 Main Street, Suite 650 Kansas City, Missouri 64112   David N. Sosland Trust A 4801 Main Street, Suite 650 Kansas City, Missouri 64112   Sosland Family Trust B Partnership 4801 Main Street, Suite 650 Kansas City, Missouri 64112   The Sosland Foundation 4801 Main Street, Suite 650 Kansas City, Missouri 64112
Item 2(c).	Citizenship.   Morton I. Sosland is a citizen of the United States of America.   David N. Sosland Trust A is a Missouri trust.   Sosland Family Trust B Partnership is a Missouri partnership.   The Sosland Foundation is a Missouri non-profit corporation.
Item 2(d).	Title of Class of Securities:
	Common Stock, par value $0.0001 per share (the “Common Stock”)
Item 2(e).	CUSIP Number:
	46116X 101
Item 3.	Not applicable.

 

---

 Page 7 of 10

Item 4.	Ownership.
	(a)	Amount beneficially owned:
		Morton I. Sosland is the beneficial owner of 3,388,389 shares of Common Stock.   The David N. Sosland Trust A is the beneficial owner of 707,287 shares of Common Stock.   The Sosland Family Trust B Partnership is the beneficial owner of 1,948,554 shares of Common Stock.   The Sosland Foundation is the beneficial owner of 732,548 shares of Common Stock.
	(b)	Percent of class:
		Morton I. Sosland is the beneficial owner of 11.53% of the outstanding shares of Common Stock.   The David N. Sosland Trust A is the beneficial owner of 2.41% of the outstanding shares of Common Stock.   The Sosland Family Trust B Partnership is the beneficial owner of 6.63% of the outstanding shares of Common Stock.   The Sosland Foundation is the beneficial owner of 2.49% of the outstanding shares of Common Stock.
	(c)	Number of shares to which such person has power to vote, or direct the vote of, or to dispose, or to direct the disposition, of the shares:
		As the Trustee of The David N. Sosland Trust A, Morton I. Sosland may direct the vote and disposition of all of the shares of Common Stock held by The David N. Sosland Trust.   As the Managing Partner of The Sosland Family Trust B Partnership, Morton I. Sosland may direct the vote and disposition of all of the shares of Common Stock held by The Sosland Family Trust B Partnership.   As the Vice Chairman of The Sosland Foundation, Morton I. Sosland  may direct the vote and disposition of all of the shares of Common Stock held by The Sosland Foundation.
Item 5.	Ownership of Five Percent or Less of a Class.
	Not applicable.
Item 6.	Ownership of More than Five Percent on Behalf of Another Person.
	Not applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported By the Parent Holding Company.
	Not applicable

 

 

---

Page 8 of 10

 

Item 8.	Identification and Classification of Members of the Group.
	Not applicable
Item 9.	Notice of Dissolution of a Group.
	Not applicable
Item 10.	Certification.
	By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
Exhibits	Exhibit A
	Joint Filing Agreement dated September 9, 2013, by and among Morton I. Sosland, The David N. Sosland Trust A, The Sosland Family Trust B Partnership and The Sosland Foundation.

---

Page 9 of 10

 

SIGNATURE

After reasonable inquiry and to the best of his or her knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

Dated:

February 4, 2015

By:		/s/ Morton I. Sosland
		Morton I. Sosland

	David N. Sosland Trust A
By:		/s/ Morton I. Sosland
		Morton I. Sosland, as Trustee

	Sosland Family Trust B Partnership
By:		/s/ Morton I. Sosland
		Morton I. Sosland, as Managing Partner

	The Sosland Foundation
By:		/s/ Morton I. Sosland
		Morton I. Sosland, as Vice Chairman

---

Page 10 of 10

 

EXHIBIT A

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock of Intra-Cellular Therapies, Inc., and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filings.

This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the same instrument.

Dated:  February 4, 2015